Robert E. Ratner, MD, talks about how the ADA is working to identify prediabetes and delay the onset as much as possible of diabetes. He explains that screening is extremely important and that this process also provides an opportunity for intervention. He also emphasizes that lifestyle modification is the first step …
Read More »Yearly Archives: 2015
Why a Low-Carb Diet Should Be the First Approach in Diabetes Treatment
The current state of diabetes care in the United States health system shows the inability of existing recommendations to control the epidemic of diabetes, the failure of low-fat diets to improve obesity rates, cardiovascular risk or general health, and the continual reports of serious side effects of commonly prescribed diabetic medications...
Read More »The Present and Future of Insulin Therapy Part 8
In this week’s Homerun Slides, a closer look at the workings and efficacy of DPP-4 inhibitors… To download the complete set in PowerPoint format, just use this link: The Present and Future of Insulin Therapy in the Era of Pathophysiologic Treatment of T2DM, Part 8 Catch up on past …
Read More »The Present and Future of Insulin Therapy Part 7
In this week's Homerun Slides, incretins, an explanation of the glucose-stimulated secretion of insulin and the effect of exenatide versus glargine insulin on insulin secretion in type 2 diabetes...
Read More »Christophe Arbet-Engels, MD, Q3: Cooperation between Boehringer and Lilly
Dr. Christophe Arbet-Engels explains how Eli Lilly and Boehringer Ingelheim have created and alliance and what that means in terms of promotion. Christophe Arbet-Engels, MD, PhD, MBA, is vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim Pharmaceuticals, Inc. See more SGLT-2 Resources
Read More »Selecting the Best ARB for Your Patients
Tool for Your Practice (Subscribers Only)
Read More »Letter From the Editor, Sept. 19, 2015
It seems like every time we get good news about a diabetes drug, the bad has to surface. This week, Lilly and BI announced some great heart results with their drug Jardiance, while the FDA tightened up its warning on Invokana and fracture risk. The same thing happens in other …
Read More »How to Talk with Patients About Their Prediabetes Diagnosis
Tool for Your Practice (Subscribers Only)
Read More »HealthSuite Digital Platform
Product of the Week - connected digital health prototype enables people living with diabetes and their health care providers to make more confident care decisions, while managing the complexity of diabetes self-care.
Read More »The Dangers of Hyponatremia: Better Dehydrated Than Overhydrated During Exercise
An updated position statement on the dangers of hyponatremia (also known as water intoxication) was just released (1). It once again highlights how drinking too much water or any fluids during physical activity in the hopes of preventing dehydration can be potentially fatal...
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.